登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Net loss Intellia Therapeutics 2014-2024
Net loss Intellia Therapeutics 2014-2024
收藏
Statista
2026-04-11 收录
基因编辑企业财务
制药研发支出
数据链接:
https://www.statista.com/statistics/1097484/net-loss-intellia-therapeutics/
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Net loss of Intellia Therapeutics from 2014 to 2024 (in million U.S. dollars)
应用场景:
相关数据集
AstraZeneca R&D expenditure as revenue share 2006-2025
制药研发支出
行业与企业财务分析
Research & development expenditure of AstraZeneca as a percentage of total revenue from 2006 to 2025
Statista
7
0
Bristol-Myers Squibb's R&D expenses 2015-2025
制药研发支出
研发支出分析
Research and development expenses of Bristol-Myers Squibb from 2015 to 2025 (in million U.S. dollars)
Statista
5
0
Pharmaceutical product innovation expenditure in Germany 2008-2025
制药研发支出
行业经济统计
Innovation expenditure in the manufacturing of pharmaceutical products industry in Germany from 2008 to 2025 (in billion euros)
Statista
4
0
Data for independent undergraduate research: cleaned data for "COVID-19 and the Uneven Impact on Pharmaceutical Innovation: Evidence from China and the EU"
制药研发支出
疫情经济影响
The sample is drawn from the Industrial R&D Investment Scoreboard published by the IRI/JRC, which tracks the world’s top 1000 firms by R&D spending. Chinese and EU-based pharmaceutical companies form
NIAID Data Ecosystem
6
0
Takeda Pharmaceutical's R&D expenses FY 2018-2024
制药研发支出
医药行业财务
Research and development (R&D) expenses of Takeda Pharmaceutical Co., Ltd. from fiscal year 2018 to 2024 (in billion Japanese yen)
Statista
5
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广